While this inhibition was attempting to target Trypanosoma Brucei, this compound could also be a potential therapeutic tool for breast cancer, since 6PGL was found to be overexpressed in human epidermal growth factor receptor 2 (HER2) positive breast cancer cells [41,42]. This evidence concerns the gene PGLS and breast cancer.